- Filed
- Jun 11, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Jun 11, 2021 | 18.55M sh |
| Operating Cash Flow | Q2 2021 · Mar 31, 2021 | −$660.65K |
| Operating Cash Flow | Q2 2021 · Mar 31, 2020 | −$574.49K |
| Cash And Equivalents | Q2 2021 · Mar 31, 2021 | $295.15K |
| Cash And Equivalents | Q2 2021 · Sep 30, 2020 | $955.8K |
| Cash And Equivalents | Q2 2021 · Mar 31, 2020 | $1.16M |
| Cash And Equivalents | Q2 2021 · Sep 30, 2019 | $27.83K |
| Stockholders Equity | Q2 2021 · Mar 31, 2021 | −$23.34M |
| Stockholders Equity | Q2 2021 · Dec 31, 2020 | $5M |
| Stockholders Equity | Q2 2021 · Sep 30, 2020 | $5M |
| Stockholders Equity | Q2 2021 · Mar 31, 2020 | $5M |
| Stockholders Equity | Q2 2021 · Dec 31, 2019 | $5M |
| Stockholders Equity | Q2 2021 · Sep 30, 2019 | $9.83K |
| Total Liabilities | Q2 2021 · Mar 31, 2021 | $25.04M |
| Total Liabilities | Q2 2021 · Sep 30, 2020 | $25.64M |
| Current Assets | Q2 2021 · Mar 31, 2021 | $364.12K |
| Current Assets | Q2 2021 · Sep 30, 2020 | $1.05M |
| Total Assets | Q2 2021 · Mar 31, 2021 | $201.7M |
| Total Assets | Q2 2021 · Sep 30, 2020 | $202.38M |
| Eps Diluted | Q2 2021 · Mar 31, 2021 | $0.00 |
| Eps Diluted | Q2 2021 · Mar 31, 2021 | $0.00 |
| Eps Diluted | Q2 2021 · Mar 31, 2020 | $0.03 |
| Eps Diluted | Q2 2021 · Mar 31, 2020 | $0.06 |
| Eps Basic | Q2 2021 · Mar 31, 2021 | −$8,623.00 |
| Eps Basic | Q2 2021 · Mar 31, 2021 | −$37,759.00 |
| Eps Basic | Q2 2021 · Mar 31, 2020 | −$634,168.00 |
| Eps Basic | Q2 2021 · Mar 31, 2020 | −$1,221,441.00 |
| Net Income | Q2 2021 · Mar 31, 2021 | $6M |
| Net Income | Q2 2021 · Mar 31, 2021 | −$72.81K |
| Net Income restated | Q2 2021 · Mar 31, 2020 | $2.43M |
| Net Income restated | Q2 2021 · Mar 31, 2020 | $651.56K |
| Operating Income | Q2 2021 · Mar 31, 2021 | −$404.56K |
| Operating Income | Q2 2021 · Mar 31, 2021 | −$635.57K |
| Operating Income | Q2 2021 · Mar 31, 2020 | −$214.14K |
| Operating Income | Q2 2021 · Mar 31, 2020 | −$457.38K |
| Cost Of Revenue | Q2 2021 · Mar 31, 2021 | $404.56K |
| Cost Of Revenue | Q2 2021 · Mar 31, 2021 | $635.57K |
| Cost Of Revenue | Q2 2021 · Mar 31, 2020 | $214.14K |
| Cost Of Revenue | Q2 2021 · Mar 31, 2020 | $457.38K |